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Despite progress in molecular biology, the prognosis of patients
suffering from cutaneous malignant melanoma, remains unsatis-
factory (Marks and Kopf, 1995). This poor outlook is due to the
fact that once the tumour has reached the metastatic state, no cura-
tive treatment is available. To achieve real progress in the treat-
ment of melanoma, the process of metastatic formation has to be
understood, in order to provide a rational approach for its therapy. 
Metastasis is a multistep phenomenon, which involves the loos-
ening of the tumour cells from the primary tumour, the degradation
of the extracellular matrix and the invasion of the blood vessels at
the site of the primary tumour. Having reached the bloodstream,
the putative metastatic cells have to survive within the circulation
and have to attach to the endothelium at the future metastatic site.
There they have to penetrate the endothelium, degrade the basal
lamina and grow at the distant site (Hart et al, 1989; Hart and
Saini, 1992; Engers and Gabbert, 1998). Several of these steps
involve cell-to-cell and/or cell-to-matrix interactions. Therefore it
is of particular interest to study the external surface of the malig-
nant cells, which mediates these interactions. 
The outer surface of all mammalian cells, including tumour
cells, is covered by a carbohydrate rich coat, the glycocalix. The
composition of this carbohydrate coat has a profound influence
on the cells’ behaviour and changes in the sugar composition
have been associated with metastasis formation (Mitchell and
Schumacher, 1999). Changes in carbohydrate composition can be
analysed using lectins, carbohydrate-binding proteins of non-
immunological origin. One lectin in particular, Helix pomatia
agglutinin (HPA), has been extensively used in cancer research as
an indicator for poor prognosis. An association between HPA
binding to the cells of the primary tumour and a poor prognosis has
been shown for breast, colorectal, gastric and prostate cancer
(Leathem et al, 1985; Leathem and Brooks, 1987; Kakeji et al,
1991; Schumacher et al, 1994; Shirashi et al, 1992). Because of the
biological significance of these carbohydrate residues, the binding
of several lectins, each having a different carbohydrate specificity,
will be tested for its prognostic value in malignant melanoma in
this study. In this lectin-binding analysis, particular emphasis will
be placed upon the usage of 2 different methods for HPA staining
as the methodology strongly influences the prognostic value of the
staining (Brooks et al, 1996). 2 different methods for HPA binding,
a biotinylated HPA method, and an indirect method using native
HPA and an anti-HPA antibody, will be compared. 
MATERIALS AND METHODS 
Paraffin wax sections of human cutaneous malignant melanoma
from 123 patients, who underwent surgery between 1983 and 1996
in the Dermatological Hospital, University Hospital Eppendorf,
Hamburg, Germany, were investigated. The data from 100 patients
could be traced in the outpatients clinic and was followed up for 10
years. Dates of diagnosis, surgery, occurrence of first metastasis
and death and data of Clark’s level of invasion, Breslow’s vertical
tumour thickness and clinical stage were recorded from the ori-
ginal reports. Informed consent of all patients, whose tumours were
investigated, had been obtained following institutional guidelines. 
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40) and the median age was 66.5 years (range 19–97 years). 41
patients presented with stage IA tumours, 22 with IB, 32 with IIA
and 5 with IIB tumours; staging was performed according to the
recommendations of the German Dermatological Society (DDG),
(Orfanos et al, 1994). After a median follow up of 10 years, 34
patients showed clinical signs of metastasis and of these 20 had
died of metastatic disease. 
Lectin histochemistry 
Deparaffinized, 5 mm thick sections were rehydrated through 
a series of graded ethanols and incubated with 0.1% trypsin
(Biochrom KG, Berlin, Germany) in Tris-buffered saline with
calcium chloride (1 mM) and magnesium chloride (1 mM)
(Merck, Darmstadt, Germany) added (‘lectin buffer’, pH 7.6) for
15 min at 37˚C. After careful washes under running tap water,
sections were transferred into lectin buffer, washed 3 times and
then incubated with 10 mg ml–1 biotinylated lectin (HPA, PHA-L,
MAA, SNA-I, and WGA; Sigma, Darmstadt, Germany), respec-
tively, for 1 h at room temperature. (For lectins, their abbreviation
and carbohydrate specificity, see Table 1.) After careful washes in
Tris buffered saline (TBS pH 7.6), an incubation with a strepta-
vidin-alkaline phosphatase complex (Vectastain, Vector, ABC kit,
Burlingame, CA) for 30 min and further washes in TBS followed.
Alkaline phosphatase enzyme reactivity was visualized using
Naphtol-AS-biphosphate as substrate and hexatozised New
Fuchsin was used for simultaneous coupling. Slides were counter-
stained with Mayer’s hemalum solution 1:1 in distilled water for
10 s, blued under running tap water and finally mounted with
Crystal Mount (Biomeda, Foster City, CA). 
For HPA, an additional, indirect staining method, following a
standard protocol described earlier (Brooks et al, 1996) was
performed. The only variation to the described method by Brooks
et al (1996) was, that the binding sites were visualized using an
alkaline phosphatase complex instead of a peroxidase complex.
Slides were pre-treated as described above, but were then incub-
ated with native unconjugated HPA (10 mg ml–1) for 1 h at room
temperature and further washes in lectin buffer followed. After an
incubation with 10% normal swine serum (DAKO, Glostrup,
Denmark) for 30 min at room temperature, slides were incubated
overnight with a 1:100 diluted rabbit anti-HPA antibody (EY Lab,
San Mato, CA) at 4˚C. The next morning, the slides were incu-
bated with a 1:300 diluted biotinylated swine anti-rabbit antibody
(DAKO, Glostrup, Denmark) for 30 min, followed by careful
washes in lectin buffer. This was followed by an incubation with a
streptavidin-alkaline phosphate complex (Vectastain, Vector, ABC
kit, Burlingame, CA) for 30 min and additional washes in TBS.
Developing of the enzyme reactivity, counterstaining and
mounting was performed as described above. For both staining
methods, control sections were treated the same way omitting the
lectin incubation. As a positive control and for assuming staining
consistency, one case that previously stained strongly for lectin
binding was included with every batch of staining. 
Histological evaluation and statistical analysis 
For histological evaluation of the staining result, the definition of
Leathem et al (1985) was adhered to: ‘negative’ (–) indicated no
staining or very weak staining of single tumour cells less than
5%, regardless of staining pattern or staining intensity. Regular
supranuclear staining (Golgi field) of whole clusters of the
melanoma was also regarded as negative. This was done based
upon works on HPA-binding pattern in human colorectal cancer
(Schumacher et al, 1994), where this pattern of reactivity proved
to be of no prognostic value. ‘Positive’ indicated that at least 6%
of the tumour cells were stained. Microscopic evaluation was
carried out by 2 independent, blinded observers. The observers
agreed in 95% of the cases; in the remaining cases consensus was
achieved after discussion. The intra-observer reproducibility
exceeded 97%. The slides were examined under a Zeiss
Axioplan photomicroscope and photographed with a Kodak
Ektachrome 64T colour film. Statistical analysis was carried out,
preparing survival curves according to the Kaplan–Meier method
(Kaplan and Meier, 1958) for time to first metastasis, unadjusted
for clinical stage, for each of the 5 lectins, using Graph Pad
Prism (Intuitive Software for Science, San Diego, CA) on an
IBM-compatible microcomputer. Furthermore, Cox-regression
analysis for HPA binding adjusted for clinical stage were
performed using SPSS for Windows version 9 (SPSS Inc,
Chicago, Illinois, USA). 
RESULTS 
Lectin histochemistry 
A summary of all staining results is given in Table 2. 
HPA staining exhibited a very homogenous staining pattern
with both methods: either the far majority of tumour cells were
stained or no staining of the melanoma cells could be detected (see
Figure 1). Staining intensity of the indirect method was more
intense than of the biotinylated HPA method. The biotinylated
HPA method detected 25 HPA-positive tumours, of which 17 had
metastasized, while the indirect method revealed 40 HPA-positive
tumours, of which 21 had metastasized. Comparing the staining
results of the both methods for HPA, 17 tumours were positive in
both methods and of these 13 had metastasized. 
PHA-L exhibited heterogeneous intensity of tumour cell
staining within individual melanomas. 70 melanomas, of which 
22 had metastasized, contained PHA-L-positive tumour cells.
Evaluation of binding pattern of SNA-I revealed 42 positive
melanomas. 17 of the 42 SNA-I-positive melanomas and 17 of the
58 SNA-I-negative tumours had metastasized. As to the staining
characteristics of SNA-I, it was striking to note that only single
clusters of tumour cells were positive within one melanoma. MAA
did not bind to melanoma cells at all, in all 100 cases and WGA
exhibited constant positive staining of all melansomas. 
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Table 1
Lectin Abbreviation Carbohydrate specificity 
Helix pomatia HPA D-galNAc > glcNAc 
Maackia amurensis MAA a-2,3 branched sialic acid 
Sambucus nigra SNA-I a-2,6 branched sialic acid 
Phaseolus vulgaris PHA-L complex carbohydrates 
Triticum vulgaris WGA b-D-glcNAc, b-D-glcNAc NeuAc, 
galNAc > lac > gal > galNAc 
Range of used lectins, their abbreviation and carbohydrate specificity.
Carbohydrate specificity is listed in decreasing affinity. galNAc =
N-Acetylgalactosamine; glcNAc = N-Acetylglucosamine; NeuAc = neuraminic
acid; gal = galactose; glc = glucose. Survival analysis 
Univariate 
Analysis of HPA binding versus no binding was significantly
correlated with metastasis: those patients whose primary
melanomas bound HPA, had a significantly higher risk of sub-
sequent metastasis than those patients whose tumours did not bind
this lectin (see Figure 2). Both methods gave excellent correlation
with subsequent metastasis. Although, in distinguishing between
the metastatic and the non-metastatic subgroup, the biotinylated
HPA method (P < 0.0001) was slightly superior to the indirect
method (P = 0.0006). Kaplan–Meier analysis detected no corre-
lation between MAA, SNA-I, PHA-L and WGA binding to
melanoma cells and metastasis formation. 
Multivariate 
A Cox-regression model including HPA-binding status and tumour
stage coded as indicator variable demonstrated that HPA positivity is
an independent predictor for metastasis. For patients whose tumours
are HPA positive, the risk of metastasis is 2.6 times higher than for
patients with HPA negative tumours (95%CI:1.3–5.5) (see Table 3). 
DISCUSSION 
The aim of the present study was twofold: first, a possible correla-
tion between the expression of lectin-binding sites in cutaneous
malignant melanoma and the development of metastasis was
investigated and second, as the methodology strongly influences
the prognostic value of the staining (Brooks et al, 1996), 2
different methods for HPA binding, one method, using biotinylated
HPA, and an indirect method, using native HPA and an anti-HPA
antibody, were compared. 
Of the 5 lectins tested, binding of HPA was strongly correlated
with metastasis in this patient series. Multivariate analysis demon-
strated that HPA binding to primary malignant melanomas is an
independent marker for the risk of metastasis; patients with a HPA-
positive melanoma have a 2.6 times higher risk for metastasis over
patients with HPA-negative melanomas. Hence, HPA positivity is
an additional tumour cell characteristic beneath the classical
staging using tumour thickness, which places patients into 4 risk
groups. Therefore assessment of HPA-binding characteristics
would be one approach to more precisely identify the metastatic
phenotype of malignant melanoma. However, the prognostic rele-
vance of HPA now has to be validated in a bigger patient cohort,
especially when discussing prognostic markers in malignant
melanoma (Doré et al, 1997), but the results in our series of 100
patients clearly prove that HPA positivity is strongly correlated
with metastatic spread. 
HPA binding to the metastatic subtype of melanoma is not only
a useful histochemical marker for a high risk of subsequent
metastasis but also might be functionally associated with the
metastatic processes. The results of the present study strongly
support the previous hypothesis that expression of N-acetyl-galac-
tosamine (GalNAc)/-glucosamine (GlcNAc) residues on the cell
surface of malignant cells, as detected by HPA binding, is involved
in the complex process of metastatic spread. The biosynthetic
pathway of the HPA binding saccharides is hence of particular
interest. Two different ways of biosynthesis are possible: first, a
neo-expression of N-acetyl-galactosamine/-glucosamine residues
on the metastatic melanoma cells or secondly, a loss of terminal
carbohydrate residues, unmasking sub-terminal HPA-binding part-
ners could account for their HPA positivity. The latter has been
propagated for HPA-binding sites in breast and colon cancers: in
breast cancer, the pre-treatment of tissue sections with sialidase
destroyed the significance of the HPA binding results (Fenlon et al,
1987), indicating that terminal sialic acid masks HPA-binding sites
and is thus involved in the metastatic process. Furthermore, serial
analysis of gene expression (SAGE) in colon cancer and normal
colonic mucosa resulted in a significant depression of the a 2–3
sialyltransferase transcript in colon cancers (Zhang et al, 1997).
The end product of this enzyme activity can be visualized using
the a 2–3 sialic acid-specific MAA. However, the simple loss of
terminal sialic acids, as discussed above, is not sufficient to
explain the association between HPA binding and metastasis in
Lectin binding in melanoma 821
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Table 2
Lectin P value Staining pattern of  Metastasized / not
tumour cells metastasized 
HPA 25 positive 17 / 8 
biotin < 0.0001 75 negative 17 / 58 
HPA 40 positive 21 / 19 
indirect 0.0006 
60 negative 13 / 47 
MAA ns no binding at all 
PHA-L ns 70 positive 22 / 48 
0.44 
30 negative 12 / 18 
SNA-I ns 42 positive 17 / 25 
0.15 
58 negative 17 / 41 
WGA ns all positive 
ns = not significant
Figure 1 Intense (++) to very intense (+++) HPA staining of malignant
melanoma cells (indirect method). Note that the far majority of tumour cells is
stained. Very intense staining of the cell membrane and additional
cytoplasmic staining of the metastatic phenotype of malignant melanoma.
Magnification x 375. Line represents 100 mm 
Table 3 Simultaneous influence of HPA and stage on the metastatis rate.
Result of the Cox regression; hazard ratio and 95% confidence interval 
Variable Exp(B) Lower Upper 
HPA 2.62 1.25 5.48
STAGE (1) 3.43 1.12 10.51 IB versus IA 
STAGE (2) 4.78 1.73 13.15 IIA versus IA 
STAGE (3) 11.33 2.92 43.88 IIB versus IA malignant melanoma, as binding of MAA was not correlated with
metastasis. Hence, subtle differences in the carbohydrate residues
of breast cancer cells and melanoma cells, originating from
different embryonic tissues, are present in the transformation to
the metastatic phenotype. Differences in the prognostic value of
carbohydrate residues between breast cancer and malignant
melanoma are also highlighted by PHA-L. This lectin proved to be
of prognostic significance in breast and colon cancers (Fernandes
et al, 1991), however, no such significance could be detected in
our series of malignant melanomas. 
HPA positivity of the metastatic melanomas could not be
ascribed to a specific region of the tumour, which is in contrast to
a study on the expression of PNA binding sites, where PNA posi-
tivity was concentrated at the invading front of the primary
melanomas, suggesting a functional role of galactose residues in
cell invasion (Cochran et al, 1999). In HPA-positive melanomas,
the great majority of tumour cells bound the lectin, so that one
could speculate that GalNAc/GlucNAc residues are not involved
in tumour invasion, but into later steps of tumour progression such
as adhesion to endothelia at the evasion site from the bloodstream. 
Although several studies have demonstrated a strong relationship
between HPA binding to primary tumours and a poor prognosis in
breast (Leathem and Brooks, 1987), oesophageal (Yoshida et al,
1993) gastric (Kakeji et al, 1991), prostate (Shirashi et al, 1992) and
colorectal cancers (Ikeda et al, 1994; Schumacher et al, 1994), some
controversy over the prognostic significance of HPA binding in
different malignancies existed (Walker, 1993) and 2 reports have
failed to confirm the prognostic significance of HPA binding to the
metastatic phenotype in breast cancer (Galea et al, 1991; Gusterson
et al, 1993). As Galea et al (1991) and Gusterson et al (1993) used
HPA, which was directly conjugated with horseradish peroxidase
and all other reports used native HPA, which was detected using
anti-HPA antibodies and immunoperoxidase techniques, it is likely
that the different methodology used, resulted in the difference of the
results. Indeed, Brooks et al (1996) could show in one study
involving 373 patients that the methodology critically influences the
outcome of the studies. To further resolve the problem, which
methodology is the appropriate one to determine lectin binding, this
study compared a biotinylated HPA method and an indirect method
for HPA binding in serial sections. To be able to directly compare
the effect of biotinylation on lectin binding, a streptavidin-alkaline
phosphatase detection kit (ABC kit) was used for both methods, as
influences on the sensitivity as a consequence of amplification
through a biotin–streptavidin complex have been previously
822 A Thies et al 
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Figure 2 Kaplan–Meier analysis of time to first metastasis for HPA-stainers (HPA+) versus non-stainers (HPA–); (a) biotinylated method and (b) indirect
method. Those patients, whose tumours expressed HPA-binding sites had a significant higher risk of subsequent metastasis than those patients whose
melanomas were HPA negative described (Hsu et al, 1981). Furthermore, all tissue samples were
collected from the same department, where they were routinely
fixed and processed in the same way so that influences through
different processing, which also influences HPA binding sites
(Schumacher et al, 1995), can probably be neglected. Both the clas-
sical indirect method (P = 0.0006) and the biotinylated method (P <
0.0001) proved to show excellent correlation between HPA binding
and metastasis in malignant melanoma. Consistent with this correla-
tion, the staining of many melanomas was identical with both
methods. The biotinylated HPA method with a specificity of 78%
was slightly superior to the indirect method with a specificity of
71%. This contrasts with findings reported in breast cancer, where
the indirect method showed a strong correlation between binding
and long-term survival, whereas the direct method was only weakly
correlated with prognosis (Brooks et al, 1996). The authors
explained this by the fact that the lectin, used for the indirect
method, was conjugated to the comparatively large horseradish
peroxidase molecule, which might interfere sterically with the lectin
binding. In our study, however, the lectin used for the direct method
was conjugated to biotin, which has now been proved to have less
influence on the lectin-binding site. Another factor, which might
account for the differences between the 2 studies is that alkaline
phosphatase was used as a detection molecule, which was necessary
as the melanin pigment interferes with the brown reaction product of 
the horseradish peroxidase. Hence, the suggestion by Brooks et al
(1996) that the covalent coupling of HRP to HPA causes alterations
of the HPA sugar-binding site is still valid. Altogether the results of
this study demonstrate that alteration of the binding characteristics
of HPA by biotinylation are not significant and therefore the biotiny-
lated method should be the method of choice for future lectin-histo-
chemical studies. 
Comparing the results of this clinical study with result on lectin-
binding pattern in the melanoma/nude mouse model, as proposed
by Kjionniksen et al (1994), demonstrating that HPA-positive
human melanoma cell lines metastasize spontaneously in nude
mice, while HPA-negative cell lines do not, appropriately reflects
the clinical situation. In contrast, the mouse melanoma study 
by Tao and Burger (1982), implicating that WGA-binding sites
expressed on melanoma cells play a role in metastasis formation,
are incongruent with the findings in our clinical study, where
WGA was not of prognostic significance. Hence, the mouse
melanoma models are not directly transferable to a clinical situa-
tion with respect to the carbohydrate expression pattern. 
In conclusion, the results of the present study prove that HPA is
a reliable and independent prognostic marker for the metastatic
potential in human cutaneous malignant melanoma. In contrast,
complex type oligosaccharides and sialic acid residues, which
have been implicated to play a functional role in metastasis forma-
tion in other malignancies, are of no importance for the metastatic
spread in this tumour entity. 
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